LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT03412890 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

477

Enrollment

INDUSTRY

Sponsor class

Conditions

Heavy Menstrual Bleeding
Uterine Fibroid

Interventions

DRUG: Relugolix
DRUG: Estradiol/norethindrone acetate

Sponsor

Myovant Sciences GmbH